Status:
UNKNOWN
Stereotactic Aspiration for Primary Brainstem Hemorrhage Based on 'Zhe-er Classification'
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Primary Brainstem Hemorrhage
Eligibility:
All Genders
Brief Summary
The purpose of this study is to determine the benefit of stereotaxic aspiration for patients with primary brainstem hemorrhage with the guidance of 'Zhe-er Classification'
Detailed Description
This is a retrospective study aiming to analyze the clinical record of patients from March 2014 to October 2020. This study is indicated for primary brainstem hemorrhage.
Eligibility Criteria
Inclusion
- no new patients will be enrolled within this project
- Patients undergoing a stereotaxic aspiration or conservative therapy from 3/2014 to 10/2020 in 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Exclusion
- patients with secondary brainstem hemorrhage due to blood vessel malformation, trauma, or malignancies
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT04910490
Start Date
November 1 2020
End Date
June 30 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jianmin Zhang
Hangzhou, Zhejiang, China, 310000